Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages
AssigneeSilence Therapeutics GmbH
InventorsLucas Bethge, Judith Hauptmann, Christian Frauendorf, Adrien Weingärtner
Life of this patent
Estimating the term…
Abstract
The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.
Claims30
A method of preventing or treating a disease, disorder or syndrome, the method comprising administering to a subject a composition comprising a nucleic acid for inhibiting expression of a target gene in a cell, comprising at least one duplex region that comprises at least a portion of a first strand and at least a portion of a second strand that is at least partially complementary to the first strand, wherein said first strand is at least partially complementary to at least a portion of RNA transcribed from said target gene, wherein said first and/or second strand comprises a phosphorodithioate linkage between at least two nucleotides.
A method of preventing or treating a disease, disorder or syndrome, the method comprising administering to a subject a composition comprising a nucleic acid, comprising at least one duplex region that comprises at least a portion of a first strand and at least a portion of a second strand that is at least partially complementary to the first strand, wherein said first strand is at least partially complementary to at least a portion of RNA transcribed from said target gene,
- wherein the nucleic acid comprises phosphorodithioate linkages between the two terminal nucleotides at the 3′ end of the first strand, and
- between the two terminal nucleotides at the 3′ end and the two terminal nucleotides at the 5′ end of the second strand;
- and
- wherein the first strand comprise a linkage other than a phosphorodithioate between the two, three or four terminal nucleotides at the 5′ end.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.